Active Ingredient Screening
Active Ingredient Screening - Related Videos
06:16
High Throughput Screening of Fungal Endoglucanase Activity in Escherichia coli
0 Views •
Cited by 7 •
2011
We describe a low cost, high throughput method to screen for fungal endoglucanase activity in E. coli. The method relies on a simple visual readout of substrate degradation, does not require enzyme purification, and is highly scalable. This allows for the rapid screening of large libraries of enzyme variants.
03:52
Estrogen Receptor-Reporter Activity Assay to Screen Phytoestrogen Estrogenic Activity
0 Views •
2025
This video describes a cell-based reporter assay to determine the estrogenic activity of plant-derived compounds. A compound with estrogen-like activity mimics its binding to estrogen receptors and drives downstream reporter enzyme gene transcription. The reporter enzyme generates bioluminescence in a reaction, indicating the estrogenic activity of the compound.
10:21
A High Throughput Screen for Biomining Cellulase Activity from Metagenomic Libraries
0 Views •
Cited by 24 •
2011
This protocol describes a high throughput screen for cellulolytic activity from a metagenomic library expressed in Escherichia coli. The screen is solution based and highly automated, and uses one-pot chemistry in 384 well microplates with the final readout as an absorbance measurement.
10:25
Construction of Models for Nondestructive Prediction of Ingredient Contents in Blueberries by Near-infrared Spectroscopy Based on HPLC Measurements
0 Views •
Cited by 1 •
2016
We present here a protocol to construct and validate models for nondestructive prediction of total sugar, total organic acid, and total anthocyanin content in individual blueberries by near-infrared spectroscopy.
03:01
alamarBlue Assay: A Sensitive Fluorometric Method to Screen the Cytotoxic Effects of Artificial Tear Formulations on Metabolic Activity of Human Corneal Epithelial Cells
0 Views •
2025
This video describes an in vitro fluorometric assay to assess the effects of artificial tear formulations on the cellular metabolic activity of corneal epithelial cells using resazurin-based Alamar blue solution. A non-toxic formulation maintains the cells in a healthy, metabolically active state, facilitating the reduction of resazurin into a highly fluorescent resorufin.
FAQs
Testing candidates across relevant concentrations allows researchers to compare how the measured response changes as exposure increases or decreases. This pattern can establish a dose-response relationship rather than relying on a single observation. The resulting evidence helps distinguish stronger candidates from weaker ones and supports decisions about which substances merit further validation.
Untreated controls show the baseline response of the biological system, while reference controls provide a comparison with an established response condition. Candidate results become more interpretable when measured against both standards. These comparisons help researchers determine whether an observed change is associated with the tested substance rather than the assay background or experimental conditions.
A compound may produce a measurable response yet still require evaluation for how specifically it produces the desired effect. Screening therefore considers activity together with selectivity when candidates are compared. This distinction helps prioritize substances that are more relevant to the intended biological process and reduces reliance on response magnitude alone.
Candidates become stronger follow-up choices when they show a clear biological response under controlled conditions, a useful concentration-response pattern, and evidence of selectivity. Screening can then guide additional validation, toxicity testing, and mechanism studies. These next steps determine whether an initial signal is sufficiently reliable and informative for continued biological or drug-discovery research.
A typical workflow exposes candidate chemical or biological substances to a selected assay system, measures the resulting biological response, and compares those measurements with untreated and reference controls. Researchers examine responses across relevant concentrations, identify dose-response relationships, and prioritize candidates. Selected substances can then proceed to validation, toxicity testing, or mechanism studies.
The assay system determines which biological response can be measured and therefore shapes the question the screening can address. Cells, enzymes, microorganisms, and molecular targets provide different contexts for evaluating candidate substances. Selecting among them connects the screen to goals such as signaling research, antimicrobial investigation, disease-process studies, or therapeutic development.
In biology, screening can be applied to investigate signaling pathways, examine disease processes, evaluate antimicrobial activity, and identify new research tools. Its value extends beyond finding therapeutic candidates because measurable responses can reveal substances that influence biological systems. Follow-up validation and mechanism studies can then clarify how those candidates relate to the process under investigation.